FCGR2A and neoplasm: Similar observations were reported for anti-CTLA-4, anti-GITR, and anti-OX40 antibodies in murine systems demonstrating that binding to activating FcγR results in depletion of intra-tumoral Tregs and contributes to anti-tumor activity (30, 38–40).